These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19819696)

  • 1. Synthesis and anticancer activity of novel amide derivatives of non-acetal deoxoartemisinin.
    Jung M; Park N; Moon HI; Lee Y; Chung WY; Park KK
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6303-6. PubMed ID: 19819696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
    Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
    J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile synthesis and anticancer activity of C-10 non-acetal deoxoartemisinin dimers.
    Phothongkam S; Chancharunee S; Saovapakhiran A; Wichai U; Pohmakotr M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7598-601. PubMed ID: 23103096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.
    Jeyadevan JP; Bray PG; Chadwick J; Mercer AE; Byrne A; Ward SA; Park BK; Williams DP; Cosstick R; Davies J; Higson AP; Irving E; Posner GH; O'Neill PM
    J Med Chem; 2004 Feb; 47(5):1290-8. PubMed ID: 14971909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
    Jung M; Tak J; Chung WY; Park KK
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiangiogenic activity of exo-olefinated deoxoartemisinin derivatives.
    Oh S; Jeong IH; Shin WS; Lee S
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3683-6. PubMed ID: 15203143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
    Galal AM; Gul W; Slade D; Ross SA; Feng S; Hollingshead MG; Alley MC; Kaur G; ElSohly MA
    Bioorg Med Chem; 2009 Jan; 17(2):741-51. PubMed ID: 19084416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
    Wang YQ; Li XH; He Q; Chen Y; Xie YY; Ding J; Miao ZH; Yang CH
    Eur J Med Chem; 2011 Dec; 46(12):5878-84. PubMed ID: 22000922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
    J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis and anticancer activity of highly potent novel glycolipid derivatives.
    Jung M; Lee Y; Moon HI; Jung Y; Jung H; Oh M
    Eur J Med Chem; 2009 Aug; 44(8):3120-9. PubMed ID: 19342127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
    Fang F; Wang AP; Yang SF
    Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin.
    Lee CH; Hong H; Shin J; Jung M; Shin I; Yoon J; Lee W
    Biochem Biophys Res Commun; 2000 Aug; 274(2):359-69. PubMed ID: 10913344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structure-activity relationship of 2-phenyl-oxazole-4-carboxamide derivatives as potent apoptosis inducers.
    Tai VW; Sperandio D; Shelton EJ; Litvak J; Pararajasingham K; Cebon B; Lohman J; Eksterowicz J; Kantak S; Sabbatini P; Brown C; Zeitz J; Reed C; Maske B; Graupe D; Estevez A; Oeh J; Wong D; Ni Y; Sprengeler P; Yee R; Magill C; Neri A; Cai SX; Drewe J; Qiu L; Herich J; Tseng B; Kasibhatla S; Spencer JR
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4554-8. PubMed ID: 16784854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acyl amide derivatives of doxorubicin: synthesis and in vitro anticancer activities.
    Chhikara BS; St Jean N; Mandal D; Kumar A; Parang K
    Eur J Med Chem; 2011 Jun; 46(6):2037-42. PubMed ID: 21420207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH; Jung Y; Kim TY; Kim SG; Jong HS; Lee JW; Kim DK; Lee JS; Kim NK; Kim TY; Bang YJ
    Clin Cancer Res; 2004 Aug; 10(15):5271-81. PubMed ID: 15297431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships.
    Song DQ; Wang Y; Wu LZ; Yang P; Wang YM; Gao LM; Li Y; Qu JR; Wang YH; Li YH; Du NN; Han YX; Zhang ZP; Jiang JD
    J Med Chem; 2008 Jun; 51(11):3094-103. PubMed ID: 18457382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR.
    Andrianov V; Gailite V; Lola D; Loza E; Semenikhina V; Kalvinsh I; Finn P; Petersen KD; Ritchie JW; Khan N; Tumber A; Collins LS; Vadlamudi SM; Björkling F; Sehested M
    Eur J Med Chem; 2009 Mar; 44(3):1067-85. PubMed ID: 18672316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.